AVENUE THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
AVENUE THERAPEUTICS, INC. (ATXI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $31.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2023-03-31
- AVENUE THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $31.00M, a 11.51% increase from fiscal 2021.
- AVENUE THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $27.80M, a 3.35% increase from fiscal 2020.
- AVENUE THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $26.90M.
- AVENUE THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $2.50M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2022-12-31 | $31.00M 10-K · filed 2023-03-31 |
| 2021-12-31 | $27.80M 10-K · filed 2023-03-31 |
| 2020-12-31 | $26.90M 10-K · filed 2022-03-25 |
| 2017-12-31 | $2.50M 10-K · filed 2019-03-12 |